Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2025 16:47 ET | Source: Robbins LLP

ATYR Investors: Securities Law Firm Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against aTyr Pharma, Inc.

ATyr Pharma, Inc. is being sued because the Company allegedly mislead investors regarding the efficacy of its drug candidate.
September 15, 2025 10:57 ET | Source: Block & Leviton LLP

BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Block & Leviton is investigating aTyr Pharma after the company announced that its Phase 3 trial for efzofitimod failed to meet its primary endpoint.